Valeant Canada receives Health Canada approval for insomnia drug
Valeant Canada Limited, a wholly owned subsidiary of Valeant Pharmaceuticals, has received Health Canada approval for insomnia drug Sublinox.
Merck & Co. said it achieved positive results in Phase 3 trials of its experimental insomnia treatment, a key drug in the pharmaceutical giant's pipeline.